COVID-19 and Blinatumomab Therapy: “First Do No Harm”

06.17.20

COVID-19 and Blinatumomab Therapy: “First Do No Harm”

by Eleanor Mayfield, ELS

Panel Addresses the Use of MRD in Clinical Decision Making

06.15.20

Panel Addresses the Use of MRD in Clinical Decision Making

by Eleanor Mayfield, ELS

NGS-MRD Assay Shows Promise in Real-World Analysis

06.12.20

NGS-MRD Assay Shows Promise in Real-World Analysis

by Eleanor Mayfield, ELS

An In-Depth Look at the Past and Future of Bispecific Antibodies

05.31.20

An In-Depth Look at the Past and Future of Bispecific Antibodies

by Eleanor Mayfield, ELS

Study Finds that MRD Negativity Correlates with Health-Related Quality of Life and Cost Effectiveness

05.29.20

Study Finds that MRD Negativity Correlates with Health-Related Quality of Life and Cost Effectiveness

by Eleanor Mayfield, ELS

Talking to your Patients About MRD

05.27.20

Talking to your Patients About MRD

by Kate Jacobson

New Data at ASCO Highlights Utility of MRD Monitoring

05.22.20

New Data at ASCO Highlights Utility of MRD Monitoring

by Kate Jacobson

BiTE Therapy in Multiple Myeloma

04.13.20

BiTE Therapy in Multiple Myeloma

by Kate Jacobson

Novel Blood Biopsy Detects MRD in Early-Stage Breast Cancer

04.10.20

Novel Blood Biopsy Detects MRD in Early-Stage Breast Cancer

by Kate Jacobson

Theme picker